Journal
JOURNAL OF OBSTETRICS AND GYNAECOLOGY
Volume 33, Issue 1, Pages 1-8Publisher
INFORMA HEALTHCARE
DOI: 10.3109/01443615.2012.716106
Keywords
Azathioprine; meta-analysis; 6-mercaptopurine; pregnancy
Categories
Funding
- Canadian Institutes for Health Research (CIHR)
- CIHR Vanier Canada Graduate Scholarship
Ask authors/readers for more resources
Maintaining remission of inflammatory bowel disease (IBD) during pregnancy is critical for positive pregnancy outcomes. Conflicting data exist regarding the association between thiopurine use for IBD treatment in pregnancy and adverse pregnancy outcomes and this meta-analysis aims to clarify this association. A meta-analysis was performed of all original human studies reporting outcomes in pregnancy in patients receiving thiopurines. Nine studies satisfied the inclusion criteria and a total of 494 patients with IBD and 2,782 IBD controls were reported. When compared with healthy women, those receiving thiopurines had an increased risk for congenital malformations (RR 1.45; 95% CI 1.07-1.96; p = 0.02); however, when compared with IBD controls, there was no increased risk (RR 1.37; 95% CI 0.92-2.05; p = 0.1). These data provide support for thiopurines having a minimal risk, if any, to the fetus.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available